Treatment of tinea capitis by oral terbinafin and grisofulvi

Not Applicable

• Conditions: Tinea capitis.; B35-B49; L00-L99

• Registration Number: IRCT201704056403N8
• Lead Sponsor: Vice Chancellor for research of Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Tinea documented by laboratory assessment
Exclusion criteria: Pregnancy: infancy, breastfeeding: sensitivity to terbinafin and grisofulvin: previous treatment with antifungal drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment of tinea capitis. Timepoint: The end of 2th week, 1th, 2th and 3th months. Method of measurement: clinical observation and laboratory assesment.

Secondary Outcome Measures

Name	Time	Method
Recurrence. Timepoint: The end 1 week, 1th, 2th and 3th months. Method of measurement: Clinical observation and labratory assesmsnt.;Permanent hair loss. Timepoint: The end 1 week, 1th, 2th and 3th months. Method of measurement: Clinical observation.